Swiss drug giant Novartis (NOVN.VX: Quote, Profile, Research) is considering making a major acquisition, probably in the United States, and has hired investment bank Credit Suisse First Boston to review options, a newspaper said on Thursday.
Swiss drug giant Novartis (NOVN.VX: Quote, Profile, Research) is considering making a major acquisition, probably in the United States, and has hired investment bank Credit Suisse First Boston to review options, a newspaper said on Thursday.
